Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials
Journal
International Journal of Hematology
Journal Volume
110
Journal Issue
4
Pages
466-473
Date Issued
2019
Author(s)
Dimopoulos M.A.
Moreau P.
Iida S.
Takezako N.
Chng W.J.
Zahlten-Kumeli A.
Sersch M.A.
Li J.
Huang M.
Lee J.H.
Publisher
Springer Tokyo
Type
journal article